Unfortunately, no. They provide no sales targets, revenue targets, expense targets, etc. I find this very strange to have essentially zero performance targets in place - even if you look at their own KPIs as director's it's on things like FDA approval and the stock price. I would really hope that this changes in the next report once they have more knowledge of the business and confidence in predicting the distribution channels.
Ann: Change of Director's Interest Notice, page-34
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.025(5.62%) |
Mkt cap ! $47.31M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 44.5¢ | 41.5¢ | $14.77K | 35.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19406 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 614 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MVP (ASX) Chart |